Clinical Trials Browser

Phase 3 × SCLC × 30 days × Clear all

NCT06616532 2026-05-22

PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer

Phase 3 Active not recruiting

SCLC